According to Dr. David Samadi, many drugs developed for one medical problem often becomes the holy grail for another. He’s talking about the drug Sildenafil, also known as Viagra. In published reports, researchers at the Georgia Cancer Center says Viagra could reduce the risk of colon cancer by 50 percent.
Using mice, that were genetically predisposed to colon cancer, scientists fed small amounts of Viagra in their water, resulting in a reduction of precancerous polyps. Sildenafil is a drug used for many years, not only in erectile dysfunction, but also for the treatment of premature infants with pulmonary hypertension. According to the researchers, it was also able to significantly reduce the formation of intestinal polyps in mice. The next step could be a clinical trial for the drug in patients considered to be at high risk for colorectal cancer.
Another drug, Linaclotide, used to treat constipation and irritable bowel syndrome, was also examined, but although it is effective in reducing polyps, the common side effect of diarrhea makes it unlikely that patients will find long-term use tolerable.
The “blue pill”, or Viagra is best known as the erectile dysfunction/impotence drug. Erection Disorders are the persistent or recurrent inability to achieve or maintain an erection until the completion of a sexual activity. In the search for a medicine for angina, doctors discovered this little blue pill resolved erectile difficulties, an in 1998, the pill went on the market. Dr. Samadi says drugs that are often developed for the treatment of a specific disease can be useful in many other treatments. And in many cases, researchers just happen upon the discovery.
A group of researchers revolutionized the diagnostic approach to colorectal cancer by developing genetic testing. According to Dr. David Samadi, being able to screen for cancer can improve ways to treat the disease.
Dr. Samadi, a prominent New York City urologist, with 20+ years of experience. He’s a board-certified physician, voted Top Doctor, Best Doctor, and New York’s Best Doctor for more than five consecutive years. Dr. Samadi specializes in minimally invasive surgery, and developed the The Samadi Modified Advanced Robotic Technique (SMART) surgery. He has authored more than 58 peer-reviewed medical papers, contributed to worldwide robotic surgeries, mentored medical students in laparoscopy and robotic surgery, and is a regular medical correspondent on Fox News.
Dr. Samadi is a recognized leader, Chairman of Urology at Lenox Hill Hospital, and Chief of Robotic Surgery.
Dr. David Samadi’s Social Media: www.youtube.com/user/RoboticOncology